Zolmax Metacrine, Inc. (NASDAQ:MTCR Get Rating) insider Michael York sold 107,054 shares of the businesss stock in a transaction that occurred on Thursday, January 26th. The stock was sold at an average price of $0.41, for a total value of $43,892.14. Following the transaction, the insider now directly ...\n more…
Ticker Report Metacrine, Inc. (NASDAQ:MTCR Get Rating) CEO Preston Klassen sold 380,605 shares of the firms stock in a transaction on Thursday, January 26th. The stock was sold at an average price of $0.41, for a total value of $156,048.05. Following the completion of the transaction, the chief ...\n more…